Alzheimer’s Drug Discovery Foundation Invites Proposals to Advance Digital Biomarkers for Alzheimer's and Related Dementias

Apr 13, 2019, 07:02 AM by Melodi Moore
Alzheimer's Drug Discovery
The Diagnostics Accelerator supports research and development through translational research awards and access to consulting support from industry experts. This RFP is soliciting projects to develop and validate digital biomarkers for Alzheimer's disease and related dementias. Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected, measured and analyzed by means of digital devices such as portables, wearables, or ambient sensors. Digital biomarkers range from computerized or app-based versions of traditional neurocognitive tests to novel technology platforms that combine multiple complex data sources into a phenotypic signature.

More information can be found here.

Letter of Intent: June 7, 2019
Invited Application Due:  August 16, 2019